循环sNinj1作为肝细胞癌的预后和严重程度的新型预测因子
1Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
概括
血清Ninj1 (Ninj1) 在肝细胞癌 (HCC) 患者中升高,与疾病严重程度相关. 高的Ninj1水平预测生存率较低,表明其作为HCC的诊断和预后生物标志物的潜力.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 细胞死亡机制 细胞死亡机制
- 生物标志物发现发现
背景情况:
- 肝细胞癌 (HCC) 的发展与细胞死亡有关.
- 在细胞死亡类型的编程死亡反应 (PMR) 中,Ninj1至关重要.
- 在HCC中Ninj1的作用仍然未被充分探索.
研究的目的:
- 调查循环Ninj1在HCC中的诊断和预后价值.
- 评估Ninj1与HCC严重程度和患者结局的相关性.
主要方法:
- 包括102名HCC患者和102名对照.
- 使用ELISA测量了血清Ninj1 (sNinj1).
- 评估了血清乳酸脱酶 (LDH) 和IL-1β.
- 与疾病阶段和评估的预后潜力相关联的生物标志物.
主要成果:
- 血清sNinj1,IL-1β和LDH在HCK患者中显著更高.
- sNinj1水平与瘤大小,转移和病期正相关.
- sNinj1显示出诊断潜力 (AUC 0.85) 并预测HCC患者的生存率较差.
结论:
- 血清sNinj1作为HCC诊断的有价值的生物标志物.
- 循环中的sNinj1显示为HCC严重程度和预后的新型预测器.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:05Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K